| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Regulatory and Clinical | VP, Regulatory & Clinical
1 company
John Vincent Hamilton last filed a Form 4 in July 2016, as VP, Regulatory and Clinical at LFWD. John Vincent Hamilton's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 5,665 shares of LFWD. The LFWD filings lean toward selling, a net 400 shares.
John Vincent Hamilton has 2 Form 4 filings on record from January 2016 to July 2016, all as VP, Regulatory and Clinical at Lifeward (LFWD), 2016.
The 5 reported transactions were 3 open-market sales, 1 stock award and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $4K.
The largest open-market sale was 329 shares of LFWD at an average $9.84 on April 13, 2016, about $3K.
Shares as reported in the last Form 4 for each company; the most recent is from July 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.